Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This new study examines the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation.

The study involves an experimental medicine trial carried out with healthy volunteers. It mirrors a previous trial undertaken with a similar group of participants. Both trials have investigated medications that are widely used to treat heart diseases, by lowering cholesterol and inflammation in the blood, atorvastatin and simvastatin. Whereas atorvastatin was linked to perceiving emotions as more negative, in contrast, simvastatin led to perceiving emotions as more positive. However, simvastatin was also seen to slightly increase subjective anxiety scores, perhaps mimicking what happens with commonly used antidepressants: an initial worsening of anxiety, later followed by an improvement in depressive and anxious symptoms.

Taken together, these findings suggest the possibility that atorvastatin might worsen depression and anxiety, while simvastatin might improve symptoms of depression, although at the expense of some increase in anxiety at the beginning of treatment.

In summary

Atorvastatin, used in the previous trial, is a highly potent statin that can reach the brain. Giving atorvastatin for seven days to healthy volunteers was associated with worse emotional perceptions, linked to later development of depressive and anxiety symptoms.

Simvastatin, used in the current trial, is a less strong statin, but it is also capable of entering the brain. Giving simvastatin for seven days to healthy volunteers was associated with a small improvement of emotional perceptions, which could in time lead to a reduction of depressive symptoms.

 

Dr Riccardo De Giorgi, study author and Wellcome Trust Doctoral Training Fellow, University of Oxford, said:

 

'Our findings are intriguing because they show that two similar medications, generally used to treat heart conditions, can not only affect the brain, but also do so in opposite ways. This provides some important insights about the effects of statins on common mental disorders, such as depression and anxiety. The ability of statins to reduce excessive inflammation could eventually lead to the development of better treatments. Further clinical studies, especially in patients currently suffering from depressive illness, are needed.'

Read the full study, An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in health volunteers, published in Psychopharmacology.


 

Similar stories

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.